Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection-Reference-Cited by-同舟云学术

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection

Published:2011-12-21 Issue:1 Volume:27 Page:149-157
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

Hsu Priscilla C,Federico Carole A,Krajden Mel,Yoshida Eric M,Bremner Karen E,Anderson Frank H,Weiss Alan A,Krahn Murray D

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2011.06813.x/fullpdf

Reference47 articles.

1. World Health Organization Viral Cancers: Hepatitis C Virus [Internet] http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html

2. World Health Organization Global Alert and Response, Hepatitis C. Surveillance and Control [Internet]. 2002 http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index4.html

3. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years;Khalili;Clin. Transplant.,2006

4. Management of hepatitis C;Teo;Br. Med. Bull.,2004

5. Health-state utilities and quality of life in hepatitis C patients;Chong;Am. J. Gastroenterol.,2003

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019;Value in Health;2024-08

2. A Systematic Literature Review and Meta-Analysis of Primary Evidence Reporting Health-State Preference Values in Chronic Hepatitis B, C, and D;Value in Health;2024-06

3. Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California;The American Journal of Managed Care;2023-10-20

4. Introduction;What Do Needle and Syringe Programs Do?;2023

5. Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective;Journal of Managed Care & Specialty Pharmacy;2022-10